Education
About Us
Working with TipRanks
Follow Us
MariMed Inc (TSE:MRMD)
:MRMD
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.01Last Year’s EPS
0Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 05, 2025
|% Change Since: -33.33%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance for MariMed, with strong wholesale revenue growth and brand performance contributing positively, while challenges in the retail segment and decreased profit margins presented significant hurdles. The company has a strategic focus on expansion and operational efficiencies to drive future growth.Company Guidance
During the MariMed, Inc. Fourth Quarter 2024 Financial Results Conference Call, the company provided several key metrics and guidance for the upcoming year. MariMed reported Q4 2024 revenue of $39 million, contributing to a record annual revenue of $158 million, marking a 6% increase from 2023. The company saw a slight improvement in gross margins, from 42.6% to 43.3% quarter-over-quarter, despite industry-wide challenges. Wholesale revenue grew by 29% year-over-year, reaching $62.9 million, driven by increased brand distribution and improved pricing strategies. Retail revenue, however, faced a decline, particularly in Illinois, due to pricing pressures and competition. MariMed's balance sheet remains strong with $78.9 million in debt, primarily in mortgages, and $7.3 million in cash. For 2025, the company aims to focus on expanding brand distribution in new and existing markets and improving profitability, while discontinuing formal financial guidance due to market volatility. MariMed also highlighted its strategic pursuit of M&A opportunities, particularly in Missouri and Ohio, and expressed interest in entering New York, New Jersey, and Pennsylvania markets.Record Annual Revenue
MariMed reported a record revenue of $158 million for the fiscal year 2024, up from $148.6 million in 2023, representing a 6% increase.
Strong Wholesale Growth
Wholesale revenue grew by 29% year-over-year, with products reaching 80% of dispensaries in Massachusetts, Maryland, and Illinois.
Brand Performance
Betty's Eddies became the number one edible brand in both Massachusetts and Maryland, contributing significantly to brand strength and market penetration.
Expansion and M&A Strategy
MariMed completed operations in new processing facilities in Missouri and Illinois and announced the acquisition of First State Compassion Center in Delaware.
Adjusted EBITDA Improvement
Adjusted EBITDA increased sequentially to $5.9 million in Q4 2024, indicating operational efficiency improvements.
---
TSE:MRMD Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
TSE:MRMD Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 05, 2025 | C$0.17 | C$0.17 | 0.00% |
| Nov 06, 2024 | C$0.21 | C$0.20 | -4.76% |
| Aug 07, 2024 | C$0.23 | C$0.23 | 0.00% |
| May 08, 2024 | C$0.35 | C$0.32 | -8.57% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does MariMed Inc (TSE:MRMD) report earnings?
MariMed Inc (TSE:MRMD) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is MariMed Inc (TSE:MRMD) earnings time?
MariMed Inc (TSE:MRMD) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:MRMD EPS forecast?
TSE:MRMD EPS forecast for the fiscal quarter 2025 (Q1) is -0.01.
---